S.No |
NAME OF FORMULATION AS PER PHARMACOPOEIA |
European Pharmacopoeia 6.0 |
|
Indian Pharmacopoeia 2007 |
|
United States Pharmacopoeia 32 |
1 |
Insulin, Bovine |
Insulin (Bovine & Porcine)-bulk |
Insulin |
2 |
Insulin, Porcine |
3 |
Insulin, Human |
Human Insulin –HI bulk |
Insulin Human |
4 |
Insulin Injection, Biphasic |
Biphasic Insulin Injection: BI+PI mix |
NA |
5 |
Insulin Injection, Biphasic isophane |
Biphasic Isophane Insulin Injection
HI formulation 25:75, 30:70 & 50:50 |
Human Insulin Isophane Suspension and Human Insulin Injection |
6 |
Insulin Injection, Isophane |
Isophane Insulin Injection HI-NPH |
Isophane Insulin Human Suspension |
7 |
Insulin Injection, Soluble |
Insulin Injection, Regular |
Insulin Human Injection |
8 |
Insulin Preparations Injectable |
Insulin Preparations |
NA |
9 |
Insulin Zinc Injectable Suspension |
Insulin Zinc Suspension –HI lente |
Insulin Human Zinc Suspension |
10 |
Insulin Zinc Injectable Suspension (Amorphous) |
Insulin Zinc Suspension Amorphous
HI formulation with no defined ratio |
NA |
11 |
Insulin Zinc Injectable Suspension (Crystalline)/ Ultralente |
Insulin Zinc Suspension Crystalline/
HI formulation Ultralente types |
Extended Insulin Human Zinc suspension (crystalline/ Ultralente) |
12 |
NA |
Protamine Zinc Insulin injection |
NA |